This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
3 Stocks to Benefit From the Steady Growth in Jobs
by Zacks Equity Research
Steadily rising U.S. jobs and falling unemployment make it judicious to invest in staffing firms like Insperity (NSP) and Cross Country Healthcare (CCRN).
Republic Services (RSG) Stock Up 12.9% in a Year: Here's Why
by Zacks Equity Research
Consecutive better-than-expected bottom-line performances, encouraging cash flow guidance and shareholder friendly moves have been aiding Republic Services' stock
Zacks.com featured highlights include: ResMed, Microsoft, Activision Blizzard, Best Buy and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: ResMed, Microsoft, Activision Blizzard, Best Buy and Insperity
5 Great Dividend Growth Stocks to Keep Volatility at Bay
by Sweta Killa
Dividend growth strategy is a major source of consistent income for investors in any type of market, though it doesn't offer dramatic price appreciation.
Insperity (NSP) Q3 Earnings Beat Estimates, Stock Up 2.5%
by Zacks Equity Research
Insperity's (NSP) third-quarter 2020 results reflect outperformance in worksite employee growth and pricing.
Insperity's (NSP) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Insperity (NSP).
Zacks Industry Outlook Highlights: Robert Half International, Insperity and Kforce
by Zacks Equity Research
Zacks Industry Outlook Highlights: Robert Half International, Insperity and Kforce
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
by Zacks Equity Research
Zacks.com featured highlights include: Meritage Homes, Vertex Pharmaceuticals, CVS Health, Amedisys and Insperity
Pick These 5 Stocks With Superb Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Meritage Homes (MTH), Vertex Pharmaceuticals (VRTX), CVS Health (CVS), Amedisys (AMED) and Insperity (NSP) are sound enough to meet financial obligations.
3 Stocks From the Promising Staffing Space to Watch Out For
by Sanjana Goswami
The coronavirus-driven dependency on technology, abrupt shift in recruitment patterns within the industry and reduction in expenses should help the Zacks Staffing industry thrive. RHI, NSP and KFRC are well positioned to witness demand surge.
Staffing Industry Up 30.4% in Past 6 Months: Stocks in Focus
by Sanjana Goswami
Coronavirus-induced strict lockdowns and market uncertainties lead to an abrupt shift in recruitment patterns within the staffing industry.
Should Value Investors Now Choose Insperity (NSP) Stock?
by Zacks Equity Research
Let's see if Insperity (NSP) stock is a good choice for value-oriented investors right now from multiple angles.
Insperity (NSP) Beats on Q2 Earnings, Updates 2020 View
by Zacks Equity Research
Insperity's (NSP) second-quarter 2020 revenues reflect decline in average number of worksite employees paid per month.
Paychex (PAYX) Q4 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
Paychex's (PAYX) fourth-quarter fiscal 2020 earnings and revenues decrease on a year-over-year basis.
FactSet (FDS) Beats Q3 Earnings Estimates, Lags Revenues
by Zacks Equity Research
FactSet's (FDS) third-quarter fiscal 2020 results benefit from higher sales of analytics, wealth management and content and technology solutions, and operating efficiency.
Accenture (ACN) Q3 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Accenture's (ACN) third-quarter fiscal 2020 earnings and revenues decrease on a year-over-year basis.
ABM Industries (ABM) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
ABM Industries (ABM) second-quarter fiscal 2020 earnings reflect margin improvement in Work Orders and operational efficiency.
H&R Block (HRB) Matches Q4 Earnings Estimate, Revenues Beat
by Zacks Equity Research
H&R Block, Inc.'s (HRB) fourth-quarter fiscal 2020 earnings and revenues declined year over year.
H&R Block's (HRB) Q4 Earnings, Revenues to be Hit by Coronavirus
by Zacks Equity Research
H&R Block's (HRB) Q4 results to reflect coronavirus-led reduction in the top and bottom lines.
DocuSign (DOCU) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
DocuSign's (DOCU) first-quarter fiscal 2021 earnings and revenues expected to reflect year-over-year growth.
Slack (WORK) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
The Atlassian acquisition is likely to have significantly benefited Slack's (WORK) paid customer growth in first-quarter fiscal 2021.
Coronavirus Crisis to Hurt Everi (EVRI) Q1 Earnings & Revenues
by Zacks Equity Research
Everi's (EVRI) Q1 results to reflect the unfavorable impact of coronavirus-led reduction in the top and bottom lines.
ABM Industries (ABM) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
ABM Industries' (ABM) second-quarter fiscal 2020 results to reflect the negative impact of the coronavirus-led reduction in the top and bottom lines.
ServiceMaster (SERV) Misses on Q1 Earnings, Withdraws View
by Zacks Equity Research
ServiceMaster's (SERV) first-quarter 2020 earnings decrease year over year.
Genpact (G) Beats Q1 Earnings Estimate Amid Coronavirus Crisis
by Zacks Equity Research
Genpact's (G) first-quarter 2020 earnings and revenues increase year over year.